Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Granzyme B in injury, inflammation, and repair.

Hiebert PR, Granville DJ.

Trends Mol Med. 2012 Dec;18(12):732-41. doi: 10.1016/j.molmed.2012.09.009. Epub 2012 Oct 22. Review.

PMID:
23099058
2.

Granzyme B degrades extracellular matrix and contributes to delayed wound closure in apolipoprotein E knockout mice.

Hiebert PR, Wu D, Granville DJ.

Cell Death Differ. 2013 Oct;20(10):1404-14. doi: 10.1038/cdd.2013.96. Epub 2013 Aug 2.

3.

[Granzyme B: an essential protease for the inflammatory response].

Berthou C, Zhang Y, Sasportes M.

Pathol Biol (Paris). 1998 Oct;46(8):617-24. Review. French.

PMID:
9871934
4.

Differential proteomic analysis distinguishes tissue repair biomarker signatures in wound exudates obtained from normal healing and chronic wounds.

Eming SA, Koch M, Krieger A, Brachvogel B, Kreft S, Bruckner-Tuderman L, Krieg T, Shannon JD, Fox JW.

J Proteome Res. 2010 Sep 3;9(9):4758-66. doi: 10.1021/pr100456d.

PMID:
20666496
5.

Granzyme B induces smooth muscle cell apoptosis in the absence of perforin: involvement of extracellular matrix degradation.

Choy JC, Hung VH, Hunter AL, Cheung PK, Motyka B, Goping IS, Sawchuk T, Bleackley RC, Podor TJ, McManus BM, Granville DJ.

Arterioscler Thromb Vasc Biol. 2004 Dec;24(12):2245-50. Epub 2004 Oct 7.

6.

Cytotoxic and non-cytotoxic roles of the CTL/NK protease granzyme B.

Afonina IS, Cullen SP, Martin SJ.

Immunol Rev. 2010 May;235(1):105-16. doi: 10.1111/j.0105-2896.2010.00908.x. Review.

PMID:
20536558
7.

The cytotoxic cell protease granzyme B initiates apoptosis in a cell-free system by proteolytic processing and activation of the ICE/CED-3 family protease, CPP32, via a novel two-step mechanism.

Martin SJ, Amarante-Mendes GP, Shi L, Chuang TH, Casiano CA, O'Brien GA, Fitzgerald P, Tan EM, Bokoch GM, Greenberg AH, Green DR.

EMBO J. 1996 May 15;15(10):2407-16.

8.

Are all granzymes cytotoxic in vivo?

Joeckel LT, Bird PI.

Biol Chem. 2014 Feb;395(2):181-202. doi: 10.1515/hsz-2013-0238. Review.

PMID:
24002663
9.

Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis in the genetically diabetic mouse.

Altavilla D, Saitta A, Cucinotta D, Galeano M, Deodato B, Colonna M, Torre V, Russo G, Sardella A, Urna G, Campo GM, Cavallari V, Squadrito G, Squadrito F.

Diabetes. 2001 Mar;50(3):667-74.

10.

The possible role of granzyme B in the pathogenesis of chronic obstructive pulmonary disease.

Ngan DA, Vickerman SV, Granville DJ, Man SF, Sin DD.

Ther Adv Respir Dis. 2009 Jun;3(3):113-29. doi: 10.1177/1753465809341965. Epub 2009 Jul 28. Review.

PMID:
19638369
11.

Biology of granzyme M: a serine protease with unique features.

de Koning PJ, Kummer JA, Bovenschen N.

Crit Rev Immunol. 2009;29(4):307-15. Review.

PMID:
19673685
12.

Granzyme B inhibits keratinocyte migration by disrupting epidermal growth factor receptor (EGFR)-mediated signaling.

Merkulova Y, Shen Y, Parkinson LG, Raithatha SA, Zhao H, Westendorf K, Sharma M, Bleackley RC, Granville DJ.

Biol Chem. 2016 Sep 1;397(9):883-95. doi: 10.1515/hsz-2016-0129.

PMID:
27060743
13.

Tissue repair and the dynamics of the extracellular matrix.

Midwood KS, Williams LV, Schwarzbauer JE.

Int J Biochem Cell Biol. 2004 Jun;36(6):1031-7. Review.

PMID:
15094118
14.

Perforin and granzyme B may contribute to skin inflammation in atopic dermatitis and psoriasis.

Yawalkar N, Schmid S, Braathen LR, Pichler WJ.

Br J Dermatol. 2001 Jun;144(6):1133-9.

PMID:
11422032
15.

Evaluating antigen-specific cytotoxicity of CD8+ T cells in fish by granzyme B-like activity.

Toda H, Yabu T, Shiba H, Moritomo T, Nakanishi T.

Vet Immunol Immunopathol. 2011 May 15;141(1-2):168-72. doi: 10.1016/j.vetimm.2011.02.020. Epub 2011 Mar 2.

PMID:
21435730
16.

Human granzyme B degrades aggrecan proteoglycan in matrix synthesized by chondrocytes.

Froelich CJ, Zhang X, Turbov J, Hudig D, Winkler U, Hanna WL.

J Immunol. 1993 Dec 15;151(12):7161-71.

PMID:
8258716
17.

Soluble granzyme B and cytotoxic T lymphocyte activity in the pathogenesis of systemic lupus erythematosus.

Shah D, Kiran R, Wanchu A, Bhatnagar A.

Cell Immunol. 2011;269(1):16-21. doi: 10.1016/j.cellimm.2011.03.004. Epub 2011 Mar 12.

PMID:
21458778
18.

Granzyme B contributes to extracellular matrix remodeling and skin aging in apolipoprotein E knockout mice.

Hiebert PR, Boivin WA, Abraham T, Pazooki S, Zhao H, Granville DJ.

Exp Gerontol. 2011 Jun;46(6):489-99. doi: 10.1016/j.exger.2011.02.004. Epub 2011 Feb 18.

PMID:
21316440
19.

Involvement of granzyme B and granulysin in the cytotoxic response in lichen planus.

Ammar M, Mokni M, Boubaker S, El Gaied A, Ben Osman A, Louzir H.

J Cutan Pathol. 2008 Jul;35(7):630-4. doi: 10.1111/j.1600-0560.2007.00892.x. Epub 2008 Mar 10.

PMID:
18331568
20.

Mouse and human granzyme B have distinct tetrapeptide specificities and abilities to recruit the bid pathway.

Casciola-Rosen L, Garcia-Calvo M, Bull HG, Becker JW, Hines T, Thornberry NA, Rosen A.

J Biol Chem. 2007 Feb 16;282(7):4545-52. Epub 2006 Dec 19.

Supplemental Content

Support Center